Oncodia expands offering to include DNA and RNA extraction for molecular pathology

medical_technical-45.jpg

Oncodia has acquired the assets of ExScale Biospecimen Solutions AB, including the rights to reagent kits and software CE marked for IVD for automated extraction of DNA and RNA from formaldehyde fixed paraffin embedded (FFPE) as well as frozen tissue. ”-This acquisition gives Oncodia a well-established and growing customer base in molecular pathology in the Nordic and Baltic countries. Adding this market leading product line in terms of turn-around time, ease of use and extraction quality to our portfolio is a first step towards horizontal integration in the mutational diagnostic workflow”, says CEO Ivaylo Stoimenov.

Share on facebook
Share on twitter
Share on linkedin